si-614
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Mar 1, 2012 (NCT01558999)
Timeline
Indications
Studied for
Mechanism of action
- FibronectinBINDING AGENT
FN1 binding agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- si-614
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05411367 | Phase 3 | Jul 28, 2022 | ORA, Inc., Seikagaku Corporation, Statistics & Data Corporation |
| NCT02205840 | Phase 2/Phase 3 (Phase 3) | Jul 1, 2014 | Seikagaku Corporation |
| NCT01558999 | Phase 2 | Mar 1, 2012 | Seikagaku Corporation |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Seikagaku Corporation | For profit | 3 | 3 | 2 | 2012 |
| ORA, Inc. | For profit | 1 | 0 | 1 | 2022 |
| Statistics & Data Corporation | For profit | 1 | 0 | 1 | 2022 |
3 organizations
Page 1 / 1